📰 Bluejay Diagnostics News
Page 3 - Bluejay Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bluejay Diagnostics. Real-time updates on events, politics, business and more.
August 25, 2023
By Chris Wack Bluejay Diagnostics shares were down 10%, to $6.97, after the company entered into a definitive agreement for the purchase and sale of 216,000...
August 18, 2023
DexCom (NASDAQ:DXCM – Get Free Report) and Bluejay Diagnostics (NASDAQ:BJDX – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability. Profitability This table compares DexCom and Bluejay Diagnostics’ net […]
July 29, 2023
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Free Report) saw a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 56,700 shares, a decline of 76.2% from the June 30th total of 238,200 shares. Based on an average trading volume of 198,700 shares, the days-to-cover ratio […]
July 28, 2023
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares are flying higher on Friday.
July 24, 2023
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
July 21, 2023
By Chris Wack Bluejay Diagnostics shares rose 13% to 29 cents after the company said its board of directors approved a reverse stock split at a ratio of...
July 21, 2023
BJDX | Complete Bluejay Diagnostics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
July 21, 2023
Bluejay Diagnostics, Inc. (BJDX) shares are up 10% on Friday after the company approved a reverse stock split of its shares at a ratio of 1-for-20. The split will reduce the number of outstanding shares from 100 million to 7.
July 21, 2023
Lobbying revenues at K Street’s top firms began to rebound from a slower start to 2023, as lawmakers set to work on a slew of must-pass bills.
July 18, 2023
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Free Report) saw a large decline in short interest in June. As of June 30th, there was short interest totalling 238,200 shares, a decline of 19.9% from the June 15th total of 297,200 shares. Currently, 2.1% of the company’s stock are short sold. Based on an average trading volume […]